Profound Medical celebrates 100th TULSA procedure

Profound Medical Corp. announced that Texas Prostate has successfully completed its 100th TULSA Procedure™. This milestone highlights the growing adoption and clinical success of Profound's innovative medical technology for prostate conditions. Achieving this procedural benchmark signifies significant progress in patient treatment and market penetration for the TULSA system. It underscores the company's commitment to advancing therapeutic options in urology and improving patient outcomes.